Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly

Save time and get answers to complex questions with AI chat

Recent Questions

How does lipitor affect glucosamine's impact on joint health?
Eldepryl parkinson's disease costs?
According to recent market data tezspire tezepelumab had a 7 1 share of paid biologic prescriptions trx in the u's from may 2023 to april 2024 recent data from statista shows tezspire's market?
Eohilia generic name?
Can certain fats reduce lipitor's cholesterol lowering?

How much annouced inital list price of viltolarsen by fda approved?

See the DrugPatentWatch profile for viltolarsen

What is the initially announced (initial) list price for viltolarsen?

The FDA-approved drug viltolarsen (Vyondys 53) was announced with an initial list price of $379,000 per year for patients. [1]

Where can I verify the announced list price?

DrugPatentWatch.com lists the announced initial list price for viltolarsen as $379,000/year. [1]

Sources

[1] DrugPatentWatch.com – Viltolarsen (Vyondys 53) initial list price

Other Questions About Viltolarsen :

Viltolarsen fda approval date? Viltolarsen sequence patent? Viltolarsen viltepso fda approval date? Viltolarsen viltepso fda approval date? Viltolarsen viltepso fda approval date? Viltolarsen viltepso fda approval date?